TELA Bio, Inc. (TELA) |
|
8.71 0.35 (4.19%)
|
08-08 00:48 |
|
Open: |
8.27 |
Pre. Close: |
8.36 |
|
High:
|
9.145 |
Low:
|
8.26 |
|
Volume:
|
59,543 |
Market Cap:
|
127(M) |
|
|
|
|
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
9.15 - 9.18 |
9.18 - 9.21 |
|
Low:
|
8.17 - 8.21 |
8.21 - 8.25 |
|
Close:
|
8.65 - 8.7 |
8.7 - 8.75 |
|
Technical analysis |
as of: 2022-08-05 4:25:46 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 11.06 One year: 12.91 |
| Support: |
Support1: 8.06  Support2: 7.19 |
| Resistance: |
Resistance1: 9.47 Resistance2: 11.06 |
| Pivot: |
8.14 |
| Moving Average: |
MA(5): 8.31 MA(20): 8.1
MA(100): 8.56  MA(250): 10.98 |
| MACD: |
MACD(12,26): 0.2 Signal(9): 0.2 |
| Stochastic oscillator: |
%K(14,3): 43.7 %D(3): 32.6 |
| RSI: |
RSI(14): 74.2 |
| 52-week: |
High: 14.9 Low: 5.15 |
| Average Vol(K): |
3-Month: 74 (K) 10-Days: 35 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ TELA ] has closed above the upper band by 21.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 58.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Sun, 07 Aug 2022
TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex - MyChesCo
Fri, 05 Aug 2022
TELA Bio to Participate in Upc - GuruFocus.com
Wed, 03 Aug 2022
TELA Bio (TELA) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Tue, 02 Aug 2022
'The Return of Land To Indigenous People Is Key': Q&a With Shinnecock Kelp Farm's Tela Troge - The Good Men Project
Sun, 31 Jul 2022
Comparing Artivion (NYSE:AORT) and TELA Bio (NASDAQ:TELA) - Defense World
Fri, 29 Jul 2022
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 29, 2022 - BioSpace
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
15 (M) |
| Shares Float |
4 (M) |
|
% Held by Insiders
|
8 (%) |
|
% Held by Institutions
|
93.3 (%) |
|
Shares Short
|
1,120 (K) |
|
Shares Short P.Month
|
270 (K) |
Stock Financials |
|
EPS
|
-2.5 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0.68 |
|
Profit Margin (%)
|
-113.2 |
|
Operating Margin (%)
|
-100.7 |
|
Return on Assets (ttm)
|
-30 |
|
Return on Equity (ttm)
|
-139.2 |
|
Qtrly Rev. Growth
|
40 |
|
Gross Profit (p.s.)
|
1.31 |
|
Sales Per Share
|
2.18 |
|
EBITDA (p.s.)
|
-2.17 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-32 (M) |
|
Levered Free Cash Flow
|
-20 (M) |
Stock Valuations |
|
PE Ratio
|
-3.5 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
12.62 |
|
Price to Sales
|
3.98 |
|
Price to Cash Flow
|
-3.93 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
